跳至主要内容
临床试验/NCT04866706
NCT04866706已完成不适用

Performance and Safety of Routine Cataract Surgery With Visiol

TRB Chemedica1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
TRB Chemedica
入组人数
100
试验地点
1
主要终点
Corneal endothelial cells density in percent

研究概览

简要总结

In this clinical investigation, the performance and safety of routine cataract surgery with VISIOL will be assessed

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female aged 18 years and older;
  • Candidate for cataract surgery via phacoemulsification;
  • Ophthalmic surgeon's recommendation to use VISIOL prior to recruitment;
  • Eligible for the use of VISIOL as indicated in the instructions for use;
  • Written informed consent.

排除标准

  • Known allergy or hypersensitivity to any of VISIOL components;
  • Known pregnancy or breast feeding;
  • Participation in any other clinical research study within the last 90 days;
  • Patients with legally restricted autonomy, freedom of decision and action (e.g. those with measure of custody or judicial protection);
  • Incapacity to understand the informed consent and/or to comply with the Clinical Investigation Plan (CIP), per investigator's appreciation.

结局指标

主要结局

Corneal endothelial cells density in percent

时间窗: Change from pre-surgery Corneal endothelial cells density at Day 1, Day 7, Day 30, Day 90

The variation of corneal endothelial cells density (cells/mm2) as compared to baseline (pre-surgery) will be calculated (%)

次要结局

未报告次要终点

研究者

发起方
TRB Chemedica
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验